All In MedTech

FDA Clearance Tracker · K170926

BrainPulse 1100

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 20, 2026Latest source record: Apr 28, 2017 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Apr 28, 2017

Substantially Equivalent

Time to decision

30 days

Received Mar 29, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Special

Device class

Class II

The decision

FDA number
K170926
Device name
BrainPulse 1100
Applicant location
Mountain View, CA
Received
Mar 29, 2017
Decided
Apr 28, 2017
Decision
Substantially Equivalent
Submission type
Special

Device type

Device class
Class II
Regulation
21 CFR 882.1630

Every decision under product code POP

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code POP. The earliest in FDA's data is DEN140040, decided Aug 1, 2016.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Jan Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.